Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical ...
Henry Schein has been outperforming the S&P 500 since December 2024. Check out the price action, momentum, volume, and ...
The stock's fall snapped a four-day winning streak.
1d
Investor's Business Daily on MSNHenry Schein Shows Improved Relative Strength; Still Shy Of BenchmarkRating, from 69 to 74. Please watch the video at Investors.com - How To Find The Best IPO Stocks IBD's unique rating tracks ...
Henry Schein's market leadership and strategic acquisitions across various healthcare segments make it a solid investment, ...
StockStory.org on MSN14d
Henry Schein (NASDAQ:HSIC) Reports Sales Below Analyst Estimates In Q4 EarningsDental and medical products company Henry Schein (NASDAQ:HSIC) in Q4 CY2024, but sales rose 5.8% year on year to $3.19 billion. Its non-GAAP profit of $1.19 per share was 1.6% below analysts’ ...
Shares of Henry Schein Inc. HSIC rose 2.23% to $74.59 Friday, on what proved to be an all-around favorable trading session ...
Henry Schein, Inc. (NASDAQ:HSIC – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the ...
Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical ...
The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...
HSIC registered adjusted earnings per share (EPS) of $1.19 in the fourth quarter of 2024, up 80.3% from the year-ago period’s EPS of 66 cents. The figure was in line with the Zacks Consensus Estimate.
Meeting to be held on March 10 at 11 am hosted by Oppenheimer. Discover the Best Stocks and Maximize Your Portfolio: See what stocks are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results